SNSS @ 4.70 up 32% > Sunesis Pharmaceuticals shares are trading higher after Oppenheimer upgraded the stock from Perform to Outperform and announced a price target of $12 per share. Feb 23, 2021 8:03a ETBenzinga Stock Analysis